Portola Pharmaceuticals Announces Proposed Offering of Common Stock For Gross Proceeds Of $160M
October 01, 2014 at 16:26 PM EDT
Portola Pharmaceuticals, Inc. (Nasdaq: PTLA) today announced that it has commenced an underwritten public offering of shares of its ...
